The Innovation Score: Why R&D Intensity Predicts Long-Term Returns

Most valuation tools look backwards. They take yesterday's earnings and apply a multiple.

The problem is that value is created in the future, not the past. A company investing heavily in R&D today is building earnings power that won't show up in financials for years.

That's the gap the Innovation Score is designed to fill.

What Is the Innovation Score?

The Innovation Score is one of three signals in the Equity Rank methodology. It measures a company's innovation intensity relative to its sector peers.

It's calibrated so that 50 = sector average. Above 50 means the company invests more aggressively in future growth than peers. Below 50 means it's investing less.

What Goes Into It?

R&D Intensity: R&D expenditure as a percentage of revenue. We compare this against the sector median. A biotech spending 20% of revenue on R&D when peers spend 12% scores higher.

Patent Velocity: The rate of new patent filings and grants. Patents aren't a guarantee of commercial success, but they're an objective measure of innovation output.

Capital Discipline: High R&D spending only matters if capital is being deployed efficiently. We cross-reference R&D intensity against return on invested capital (ROIC) — because burning cash on research that never converts is not a virtue.

How It Affects Fair Value

The Innovation Score adjusts the base fair value estimate upward or downward:

Fair Value = Consensus Fair Value — (1 + sentiment_term + innovation_term)

A company with an Innovation Score of 75 (well above average) gets a positive innovation adjustment to its fair value. A company at 30 gets a discount.

The adjustment is intentionally bounded — it modifies fair value by a maximum of a few percentage points — because innovation is a supporting signal, not the whole thesis.

Why Sector Comparison Matters

An absolute R&D number is almost meaningless without context. A pharma company spending $500M on R&D might be under-investing. A retail company spending $50M might be a leader.

That's why every Innovation Score is calculated relative to the sector. It answers the question: is this company innovating more or less aggressively than the companies it competes with?

What the Innovation Score Is Not

It's not a prediction that innovation will succeed. Plenty of companies with high R&D intensity fail to commercialise it.

It's not a standalone buy signal. A company can have a high Innovation Score and still be overvalued.

It's one dimension of a multi-signal assessment. When the Innovation Score aligns with a strong SAVE Score and a meaningful margin of safety, you have three independent signals pointing in the same direction.

Explore Innovation Scores for any stock

Educational content. Not financial advice. Past innovation investment does not guarantee future returns.